111 filings
F-3
SLN
Silence Therapeutics Plc
7 May 24
Shelf registration (foreign)
5:03pm
6-K
SLN
Silence Therapeutics Plc
1 May 24
Current report (foreign)
4:37pm
6-K
SLN
Silence Therapeutics Plc
29 Apr 24
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
8:36am
6-K
SLN
Silence Therapeutics Plc
15 Apr 24
Current report (foreign)
7:00am
20-F
2023 FY
SLN
Silence Therapeutics Plc
Annual report (foreign)
13 Mar 24
8:52am
6-K
xyiff4dtmcdbg83kj
13 Mar 24
Current report (foreign)
7:10am
6-K
j06sgc693u17
23 Feb 24
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca
8:12am
6-K
83k7 wvhp6c62n
6 Feb 24
Securities Purchase Agreement
12:00am
6-K
jkuetq18dqe727
1 Dec 23
Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
7:00am
6-K
zq51fte5d
14 Nov 23
Current report (foreign)
12:00am
6-K
muvemzkj2nuh16ktf
1 Nov 23
Current report (foreign)
7:00am
6-K/A
etrd qqir5o8v4i2c
29 Aug 23
Current report (foreign) (amended)
4:01pm
6-K
n2zm1t
16 Aug 23
Current report (foreign)
7:00am
S-8
1r5h57q 6nhui
1 Aug 23
Registration of securities for employees
4:31pm
6-K
kg4ky9y
11 Jul 23
Silence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaboration
7:00am
6-K
tu5r40w9b
3 Jul 23
Current report (foreign)
7:30am
6-K
6qkji67p2
16 May 23
Current report (foreign)
4:01pm
6-K
we7eefvror4gxbvds
4 May 23
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration
7:41am
6-K
qxn4vklsfl
1 May 23
Current report (foreign)
7:31am
6-K
lfxmphhz sqsxrk
27 Apr 23
Current report (foreign)
4:31pm